retatrutide pancreatitis risk GLP-1 Agonists and Risk: Reassessing an Old Concern with New Evidence Mounjaro vs retatrutide? Comparing Effectiveness,

This suggests that weight loss with retatrutide may continue beyond the first 18 months of treatment, rather than plateauing early

Havas, a global communications agency, is convening a session on the GLP-1 revolution in culture and consumption, leveraging the companys expertise in its TRIPTK group with experts from sister company Havas Health and the YMCA of Metro Chicago adding the organizations gravitas in the discussion

clinician determines final eligibility Who shouldn't apply: Personal or family history of medullary thyroid carcinoma or MEN 2 syndrome, history of pancreatitis, certain severe GI or kidney conditions, pregnancy, or breastfeeding - clinician screens at intake FDA regulatory status as of June 2026: Active enforcement and regulatory change ongoing

Waist circumference also dropped more on tirzepatide (-18.4 cm vs -13.0 cm)

Bodybuilding, supplements and hormone use